Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes
HK Reddel, LB Bacharier, ED Bateman… - American journal of …, 2022 - atsjournals.org
The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually
updated evidence-based strategy for asthma management and prevention, which can be …
updated evidence-based strategy for asthma management and prevention, which can be …
[HTML][HTML] Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update
ML Levy, LB Bacharier, E Bateman, LP Boulet… - NPJ primary care …, 2023 - nature.com
Abstract The Global Initiative for Asthma (GINA) was established in 1993 by the World
Health Organization and the US National Heart Lung and Blood Institute to improve asthma …
Health Organization and the US National Heart Lung and Blood Institute to improve asthma …
[HTML][HTML] As-needed budesonide–formoterol versus maintenance budesonide in mild asthma
Background Patients with mild asthma often rely on inhaled short-acting β2-agonists for
symptom relief and have poor adherence to maintenance therapy. Another approach might …
symptom relief and have poor adherence to maintenance therapy. Another approach might …
GINA 2019: a fundamental change in asthma management: treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and …
GINA no longer recommends treating adults/adolescents with asthma with short-acting
bronchodilators alone. Instead, they should receive symptom-driven (in mild asthma) or a …
bronchodilators alone. Instead, they should receive symptom-driven (in mild asthma) or a …
A summary of the new GINA strategy: a roadmap to asthma control
HK Reddel, ED Bateman, A Becker… - European …, 2015 - Eur Respiratory Soc
Over the past 20 years, the Global Initiative for Asthma (GINA) has regularly published and
annually updated a global strategy for asthma management and prevention that has formed …
annually updated a global strategy for asthma management and prevention that has formed …
Metabolomic profiling reveals extensive adrenal suppression due to inhaled corticosteroid therapy in asthma
The application of large-scale metabolomic profiling provides new opportunities for realizing
the potential of omics-based precision medicine for asthma. By leveraging data from over …
the potential of omics-based precision medicine for asthma. By leveraging data from over …
Japanese guidelines for adult asthma 2020
Y Nakamura, J Tamaoki, H Nagase… - Allergology …, 2020 - jstage.jst.go.jp
abstract Bronchial asthma is characterized by chronic airway inflammation, which manifests
clinically as variable airway narrowing (wheezes and dyspnea) and cough. Long-standing …
clinically as variable airway narrowing (wheezes and dyspnea) and cough. Long-standing …
Asthma management in low and middle income countries: case for change
Asthma is the most common noncommunicable disease in children, and among the most
common in adults. The great majority of people with asthma live in low and middle income …
common in adults. The great majority of people with asthma live in low and middle income …
What is asthma− COPD overlap syndrome? Towards a consensus definition from a round table discussion
Patients with asthma–chronic obstructive pulmonary disease overlap syndrome (ACOS)
have been largely excluded from pivotal therapeutic trials and, as a result, its treatment …
have been largely excluded from pivotal therapeutic trials and, as a result, its treatment …
[HTML][HTML] Diagnosis and management of asthma in children
J Martin, J Townshend, M Brodlie - BMJ Paediatrics Open, 2022 - ncbi.nlm.nih.gov
Asthma is the the most common chronic respiratory condition of childhood worldwide, with
around 14% of children and young people affected. Despite the high prevalence, paediatric …
around 14% of children and young people affected. Despite the high prevalence, paediatric …